Amerigo Resources announced its third and largest 2026 performance dividend of Cdn$0.21 per share, payable October 14, 2026, bringing total 2026 performance dividends to Cdn$0.55 per share. This dividend reflects strong operational and financial results and is part of Amerigo's Capital Return Strategy to return excess cash while maintaining a debt-free balance sheet. Including quarterly dividends and share buybacks, the total yield for 2026 reaches 8.6%, highlighting significant shareholder returns. Since 2021, Amerigo has returned approximately $190.5 million to shareholders through dividends and buybacks, reinforcing its commitment to disciplined capital management.
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...
Meridian International Center announced its inaugural New Architects of American Influence cohort, recognizing 25 leaders from business, technology, culture, sports, and government who are shaping U.S. global influence. The 2026 cohort includes leade...
